Practical Pearls to Maximize Direct Immunofluorescence Yield in Pemphigus and Pemphigoid Disorders

Dr. Alina Bridges, a triple board-certified specialist in dermatology, dermatopathology, and immunodermatology, discusses the approach to diagnosing pemphigus and pemphigoid disorders. She emphasizes the importance of utilizing direct immunofluorescence (DIF) as a diagnostic tool while also considering other tests like serologic assays. Dr. Bridges outlines several key points, including the need for high suspicion of autoimmune blistering disorders based on clinical presentations and histopathological findings. She describes various forms of pemphigus and pemphigoid, highlighting their clinical variations and drug-induced manifestations. Dr. Bridges stresses the significance of ensuring proper biopsy techniques to retain blister samples, which provide crucial insights during DIF. She reviews histopathological patterns observed in pemphigus and pemphigoid, emphasizing the varying immunofluorescence patterns associated with different diseases. Furthermore, she discusses the role of serologic testing in confirming diagnoses and monitoring treatment efficacy while acknowledging the impact of associated medications and systemic disorders. Her take-home messages encourage clinicians to maintain a high index of suspicion for these diseases, employ comprehensive diagnostic approaches, and be vigilant regarding associated conditions to enhance patient outcomes.